These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10583887)

  • 1. Monitoring the clearance of fetal RhD-positive red cells in FMH following RhD immunoglobulin administration.
    Lubenko A; Williams M; Johnson A; Pluck J; Armstrong D; MacLennan S
    Transfus Med; 1999 Dec; 9(4):331-5. PubMed ID: 10583887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
    Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
    Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting program.
    Akers C; Savoia H; Kane S; Crispin P; Keegan A; Wood E; Glazebrook B; Bielby L; Davis AK
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):161-164. PubMed ID: 30187454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of RhD agglutination for the detection of weak D red cells by anti-D flow cytometry.
    Grey DE; Davies JI; Connolly M; Fong EA; Erber WN
    Clin Lab Haematol; 2005 Apr; 27(2):127-33. PubMed ID: 15784128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.
    Urgessa F; Tsegaye A; Gebrehiwot Y; Birhanu A
    BMC Pregnancy Childbirth; 2014 Nov; 14():358. PubMed ID: 25381160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of maternal isoimmunization to RhD antigen].
    Baptista González HA; Rosenfeld Mann F
    Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858
    [No Abstract]   [Full Text] [Related]  

  • 12. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D.
    Kumpel BM
    Transfusion; 2001 Aug; 41(8):1059-63. PubMed ID: 11493739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow Cytometry in Detection of Fetal Red Blood Cells and Maternal F Cells to Identify Fetomaternal Hemorrhage.
    Farias MG; Dal Bó S; Castro SM; da Silva AR; Bonazzoni J; Scotti L; Costa SH
    Fetal Pediatr Pathol; 2016; 35(6):385-391. PubMed ID: 27494244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of estimation of volume of fetomaternal hemorrhage using Kleihauer-Betke test and microcolumn gel method in D-negative nonisoimmunized mothers.
    Mittal K; Marwaha N; Kumar P; Saha SC; Thakral B
    Immunohematology; 2013; 29(3):105-9. PubMed ID: 24325171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
    Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
    BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration.
    Ryan MJ; Joyce S; O'Brien N; Lynch E; Burke G; Cahill MR
    Ir J Med Sci; 2005; 174(3):58-63. PubMed ID: 16285341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage.
    Chambers E; Davies L; Evans S; Birchall J; Kumpel B
    Transfus Med; 2012 Jun; 22(3):199-204. PubMed ID: 22429383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry.
    Lloyd-Evans P; Kumpel BM; Bromelow I; Austin E; Taylor E
    Transfusion; 1996 May; 36(5):432-7. PubMed ID: 8693508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.